Skip to main content
BIOPHARMA CREDIT PLC logo

BIOPHARMA CREDIT PLC — Investor Relations & Filings

Ticker · BPCR ISIN · GB00BDGKMY29 LEI · 213800AV55PYXAS7SY24 IL Financial and insurance activities
Filings indexed 734 across all filing types
Latest filing 2025-09-18 Notice of Dividend Amou…
Country GB United Kingdom
Listing IL BPCR

About BIOPHARMA CREDIT PLC

https://bpcruk.com/

BioPharma Credit PLC is a specialist investment trust that provides debt capital to the life sciences industry. The company's primary objective is to generate long-term, sustainable income for shareholders by investing in a diversified portfolio of interest-bearing debt assets. These investments are typically secured by royalties, revenue streams, and other cash flows derived from approved pharmaceutical products and healthcare technologies. This strategy offers investors exposure to the life sciences sector through debt instruments while providing financing to companies for growth and development.

Recent filings

Filing Released Lang Actions
Dividend Declaration
Notice of Dividend Amount Classification · 100% confidence The document is an official announcement from BioPharma Credit PLC regarding the declaration of an interim and special dividend. It specifies the dividend amount per share, the ex-dividend date, the payment date, and details regarding currency election. This aligns perfectly with the definition for a Notice of Dividend Amount (DIV).
2025-09-18 English
NEW INVESTMENT OF UP TO US$62.5 MILLION
Capital/Financing Update Classification · 100% confidence The document is an announcement from BioPharma Credit PLC regarding a new senior secured loan agreement (financing activity) with Precigen, Inc. It details the investment amount, tranches, maturity date, and interest rate terms. This falls under the category of company financing and capital structure updates.
2025-09-03 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is a standard regulatory notification regarding 'Total Voting Rights' issued by BioPharma Credit PLC. It provides the total number of shares and voting rights as of a specific date (31 August 2025) to comply with the FCA's Disclosure Guidance and Transparency Rules. While it mentions voting rights, it is not a declaration of results from a specific shareholder meeting (DVA), but rather a routine regulatory disclosure of capital structure. As it does not fit into the specific categories for share issues or director dealings, it falls under the general regulatory filing category.
2025-09-01 English
Notice of Half Year Results
Report Publication Announcement Classification · 100% confidence The document is a short announcement (under 2,500 characters) from BioPharma Credit PLC titled 'NOTICE OF HALF YEAR RESULTS'. It informs stakeholders that the company will announce its Half Year Results on a future date (22 September 2025). Per the 'Menu vs Meal' rule, this is an announcement regarding the publication of a report rather than the report itself, making it a Report Publication Announcement (RPA).
2025-08-26 English
Net Asset Value(s) and Monthly Factsheet
Net Asset Value Classification · 100% confidence The document is a short announcement from BioPharma Credit PLC reporting the unaudited net asset value (NAV) per share as of July 31, 2025. It is distributed via the RNS (Regulatory News Service) and explicitly mentions the NAV figure. Since the primary purpose is to report the NAV, it falls under the NAV category.
2025-08-22 English
Transaction in Own Shares - Correction
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from BioPharma Credit PLC regarding the purchase of its own shares (share buyback). It explicitly details the number of shares purchased, the price per share, and the updated treasury share count. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-08-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.